| Loss of NAD-dependent protein deacetylase sirtuin-2 alters mitochondrial protein acetylation and dysregulates mitophagy G Liu, SH Park, M Imbesi, WJ Nathan, X Zou, Y Zhu, H Jiang, L Parisiadou, ... Antioxidants & redox signaling 26 (15), 849-863, 2017 | 126 | 2017 |
| SIRT2-mediated deacetylation and tetramerization of pyruvate kinase directs glycolysis and tumor growth SH Park, O Ozden, G Liu, HY Song, Y Zhu, Y Yan, X Zou, HJ Kang, ... Cancer research 76 (13), 3802-3812, 2016 | 109 | 2016 |
| Manganese superoxide dismutase (SOD2): is there a center in the universe of mitochondrial redox signaling? X Zou, BA Ratti, JG O’Brien, SO Lautenschlager, DR Gius, MG Bonini, ... Journal of bioenergetics and biomembranes 49, 325-333, 2017 | 92 | 2017 |
| SIRT3-mediated dimerization of IDH2 directs cancer cell metabolism and tumor growth X Zou, Y Zhu, SH Park, G Liu, J O'Brien, H Jiang, D Gius Cancer research 77 (15), 3990-3999, 2017 | 76 | 2017 |
| SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins that connect mitochondrial metabolism and carcinogenesis Y Zhu, Y Yan, DR Principe, X Zou, A Vassilopoulos, D Gius Cancer & metabolism 2, 1-11, 2014 | 76 | 2014 |
| Manganese superoxide dismutase acetylation and dysregulation, due to loss of SIRT3 activity, promote a luminal B-like breast carcinogenic-permissive phenotype X Zou, CA Santa-Maria, J O'Brien, D Gius, Y Zhu Antioxidants & redox signaling 25 (6), 326-336, 2016 | 50 | 2016 |
| Lysine 68 acetylation directs MnSOD as a tetrameric detoxification complex versus a monomeric tumor promoter Y Zhu, X Zou, AE Dean, JO Brien, Y Gao, EL Tran, SH Park, G Liu, ... Nature communications 10 (1), 2399, 2019 | 43 | 2019 |
| Abstract PR001: Socioeconomic analysis and disparities in germline genetic testing for pancreatic cancer X Zou, B Sidiqi, S Patruni, C Hollweg, N Kauff, D King Cancer Research 82 (22_Supplement), PR001-PR001, 2022 | 1 | 2022 |
| Pancreatic cancer germline mutation report: An in-depth analysis of demographics, mutation profile, and patient survival. X Zou, B Sidiqi, S Patruni, C Hollweg, N Kauff, D King Journal of Clinical Oncology 40 (16), e16233, 2022 | 1 | 2022 |
| Improving timeliness and equity in germline genetic testing for pancreatic ductal adenocarcinoma patients: A comparative analysis and future strategies. X Zou, B Sidiqi, C Nguyen, E Chen, ND Kauff, D King Journal of Clinical Oncology 42 (3_suppl), 611-611, 2024 | | 2024 |
| Abstract A008: Empowering equity: Accelerated germline genetic testing for pancreatic ductal adenocarcinoma erodes delays, democratizes access, and mitigates disparity X Zou, B Sidiqi, E Chen, N Kauff, D King Cancer Research 84 (2_Supplement), A008-A008, 2024 | | 2024 |
| Empowering equity: Accelerated germline genetic testing for pancreatic ductal adenocarcinoma erodes delays, democratizes access, and mitigates disparity X Zou, B Sidiqi, E Chen, N Kauff, D King CANCER RESEARCH 84 (2), 2024 | | 2024 |
| Socioeconomic disparities causing delays in pancreatic cancer germline genetic testing. X Zou, D King, B Sidiqi, S Patruni, C Hollweg, ND Kauff Journal of Clinical Oncology 41 (4_suppl), 665-665, 2023 | | 2023 |
| Effect of neoadjuvant therapy pathway (NATP) for pancreatic cancer on overall patient outcomes. D Cooper, B Sidiqi, R Parakrama, L Demyan, S Pasha, D Pinto, ... Journal of Clinical Oncology 41 (4_suppl), 695-695, 2023 | | 2023 |
| Development of a Neoadjuvant Treatment Pathway to Standardize Pancreatic Cancer Care and Improve Outcomes Across a Large Diverse Health System R Parakrama, BU Sidiqi, L Demyan, O Standring, DJ Cooper, S Pasha, ... medRxiv, 2023.09. 19.23295749, 2023 | | 2023 |
| Socioeconomic and Demographic Barriers Associated with Delays in Pancreatic Cancer Germline Genetic Testing X Zou, B Sidiqi, S Patruni, L Rezak, C Hollweg, N Kauff, DA King medRxiv, 2023.07. 17.23292736, 2023 | | 2023 |
| Stereotactic Body Radiation Therapy (SBRT) in a Standardized Neoadjuvant Therapy Pathway for Pancreatic Cancer across a Geographically Large and Diverse Healthcare System BU Sidiqi, R Parakrama, L Demyan, J Eckstein, JD Nosrati, B Chitti, ... International Journal of Radiation Oncology, Biology, Physics 114 (3), e201, 2022 | | 2022 |
| P-10 Standardization of a neoadjuvant therapy (NAT) pathway for pancreatic cancer across a geographically large and diverse healthcare system improves patient care and … R Parakrama, B Sidiqi, L Demyan, S Pasha, D Pinto, T Zavadsky, X Zou, ... Annals of Oncology 33, S249, 2022 | | 2022 |
| Lysine 68 acetylation regulates the dichotomous role of MnSOD: a protective tetrameric detoxification complex versus a monomeric oncoprotein Y Zhu, X Zou, J O'Brien, A Dean, Y Gao, M Bonini, D Gius Free Radical Biology and Medicine 128, S77, 2018 | | 2018 |
| Aberrant Acetylation of Mitochondrial Proteins, due to Loss of SIRT3, Results in Tumor Permissive Phenotypes and Increases Breast Cancer Malignancy Risk X Zou Northwestern University, 2017 | | 2017 |
David GiusUniversity of Texas Health Sciences Center San AntonioDirección de correo verificada de northwestern.edu
